Alberta Investment Management Corp - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 142 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alberta Investment Management Corp ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$974,000
-34.6%
238,650
+1.8%
0.01%
-40.0%
Q3 2016$1,489,000
+18.8%
234,480
+0.9%
0.02%
+7.1%
Q2 2016$1,253,000
-35.6%
232,4300.0%0.01%
-46.2%
Q1 2016$1,945,000
-66.5%
232,430
-68.4%
0.03%
-61.8%
Q4 2015$5,812,000
-11.3%
735,710
-4.5%
0.07%
-10.5%
Q3 2015$6,553,000
-31.2%
770,0800.0%0.08%
-25.5%
Q2 2015$9,522,000
+234.0%
770,080
+220.9%
0.10%
+240.0%
Q1 2015$2,851,000239,9800.03%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2016
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 1,560,530$17,634,0004.71%
B & T Capital Management DBA Alpha Capital Management 280,113$3,165,0002.22%
Schonfeld Group Holdings LLC 10,000$113,0001.51%
COLUMBIA CAPITAL LLC 117,702$1,331,0001.45%
Portolan Capital Management 607,288$6,862,0001.38%
Price Capital Management, Inc. 118,047$1,334,0001.18%
GARRISON BRADFORD & ASSOCIATES INC 90,700$1,025,0000.93%
Opus Point Partners Management, LLC 72,009$814,0000.80%
EAM Investors, LLC 412,233$4,658,0000.65%
TFS CAPITAL LLC 476,105$5,380,0000.51%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders